p21
p21
₪278.00 – ₪1,092.00
p21, also known as p21Cip1 , p21Waf1, cyclin-dependent kinase inhibitor 1, or CDK-interacting protein 1, functions to regulate cell cycle progression at G1 by inhibiting the activity of Cyclin-CDK2 or -CDK4 complexes. This cyclin-dependent kinase inhibitor is expressed in all adult human tissues, and decreased expression of p21 is linked to poor prognosis in a number of carcinomas including gastric carcinoma, non-small cell lung carcinoma and thyroid carcinoma. p21 is also associated with favourable prognosis in several tumors.
| Image | Variation | SKU | Price | Quantity | Add To Cart |
|---|---|---|---|---|---|
 |
0.1ml - | IHC021-100 | ₪278.00 | |
Add to cart |
|
|
1ml - | IHC021-1 | ₪1,092.00 | |
Add to cart |
|
|
Positive Control 3 Slides - | IHC021-PC | ₪770.00 | |
Add to cart |
Description
CE-IVD registered and supplied as a concentrate.
Specifications
| Clone | IHC021 |
| Source | Mouse Monoclonal |
| Positive Control | Colon |
| Dilution Range | 1:100 – 1:200 |
References
- Winters ZE, et al. Eur J Cancer. 2001; 37:2405-12.
- Zhou BP, et al. Nat Cell Biol. 2001; 3:245-52.
- Winters ZE, et al. Breast Cancer Res. 2003; 5:R242-9.
- Dolezalova D, et al. Stem Cells. 2012; 7:1362-72.
- Almond JB, et al. Leukemia. 2002; 16:433-43.
- Gartel AL, et al. Cancer Res. 2005; 65:3980-5.
- Tamura M, et al. Ann Thorac Cardiovasc Surg. 2007; 13:9-14.
Additional information
| Units | 0.1ml, 1ml, Positive Control 3 slides |
|---|
